John L. Leguyader

Array ( [id] => 3523995 [patent_doc_number] => 05503993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'Method of preparing foreign protein in yeast, recombinant DNA, transformant' [patent_app_type] => 1 [patent_app_number] => 8/445783 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 6160 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/503/05503993.pdf [firstpage_image] =>[orig_patent_app_number] => 445783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650575 [patent_doc_number] => 05639862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Deletion muteins of hst-1' [patent_app_type] => 1 [patent_app_number] => 8/446198 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 9441 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639862.pdf [firstpage_image] =>[orig_patent_app_number] => 446198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790067 [patent_doc_number] => 05840874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Hammerhand ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/443153 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 11416 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 298 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840874.pdf [firstpage_image] =>[orig_patent_app_number] => 443153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699711 [patent_doc_number] => 05646031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'SArMV and sCYMVI hairpin ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/442513 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 9463 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646031.pdf [firstpage_image] =>[orig_patent_app_number] => 442513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700796 [patent_doc_number] => 05674747 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Viral vector coding for juvenile hormone esterase' [patent_app_type] => 1 [patent_app_number] => 8/440520 [patent_app_country] => US [patent_app_date] => 1995-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 11667 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674747.pdf [firstpage_image] =>[orig_patent_app_number] => 440520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825430 [patent_doc_number] => 05731295 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Method of reducing stromelysin RNA via ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/435634 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 57108 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731295.pdf [firstpage_image] =>[orig_patent_app_number] => 435634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665154 [patent_doc_number] => 05599704 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'ErbB2/neu targeted ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/435350 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12691 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599704.pdf [firstpage_image] =>[orig_patent_app_number] => 435350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777811 [patent_doc_number] => 05817796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'C-myb ribozymes having 2\'-5\'-linked adenylate residues' [patent_app_type] => 1 [patent_app_number] => 8/435628 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 21 [patent_no_of_words] => 116795 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817796.pdf [firstpage_image] =>[orig_patent_app_number] => 435628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775121 [patent_doc_number] => 05817635 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Modified ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/434547 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 8523 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817635.pdf [firstpage_image] =>[orig_patent_app_number] => 434547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3714551 [patent_doc_number] => 05616490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Ribozymes targeted to TNF-.alpha. RNA' [patent_app_type] => 1 [patent_app_number] => 8/434503 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14059 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616490.pdf [firstpage_image] =>[orig_patent_app_number] => 434503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626216 [patent_doc_number] => 05612469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide' [patent_app_type] => 1 [patent_app_number] => 8/431625 [patent_app_country] => US [patent_app_date] => 1995-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3019 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612469.pdf [firstpage_image] =>[orig_patent_app_number] => 431625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3521106 [patent_doc_number] => 05527529 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Vaccines comprising attenuated salmonella having mutations in the ompr genes' [patent_app_type] => 1 [patent_app_number] => 8/419741 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3837 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527529.pdf [firstpage_image] =>[orig_patent_app_number] => 419741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3875910 [patent_doc_number] => 05728549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Process for the manufacture of thrombin inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/398416 [patent_app_country] => US [patent_app_date] => 1995-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29289 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728549.pdf [firstpage_image] =>[orig_patent_app_number] => 398416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591118 [patent_doc_number] => 05521093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-28 [patent_title] => 'Yeast vector coding for heterologous gene fusions linked via KEX2 cleavage site and coding for truncated KEX2 genes' [patent_app_type] => 1 [patent_app_number] => 8/393025 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 3682 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/521/05521093.pdf [firstpage_image] =>[orig_patent_app_number] => 393025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664704 [patent_doc_number] => 05599670 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => '.beta.-glucuronidase and glucuronide permease gene system' [patent_app_type] => 1 [patent_app_number] => 8/329701 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 33895 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599670.pdf [firstpage_image] =>[orig_patent_app_number] => 329701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622362 [patent_doc_number] => 05612215 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Stromelysin targeted ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/390850 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 57688 [patent_no_of_claims] => 166 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612215.pdf [firstpage_image] =>[orig_patent_app_number] => 390850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730317 [patent_doc_number] => 05665585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Recombinant production of glucoamylase P in trichoderma' [patent_app_type] => 1 [patent_app_number] => 8/385370 [patent_app_country] => US [patent_app_date] => 1995-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 30227 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665585.pdf [firstpage_image] =>[orig_patent_app_number] => 385370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699874 [patent_doc_number] => 05646042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'C-myb targeted ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/373124 [patent_app_country] => US [patent_app_date] => 1995-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 29 [patent_no_of_words] => 28947 [patent_no_of_claims] => 220 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646042.pdf [firstpage_image] =>[orig_patent_app_number] => 373124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685337 [patent_doc_number] => 05663064 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Ribozymes with RNA protein binding site' [patent_app_type] => 1 [patent_app_number] => 8/371986 [patent_app_country] => US [patent_app_date] => 1995-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 11979 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663064.pdf [firstpage_image] =>[orig_patent_app_number] => 371986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685274 [patent_doc_number] => 05663061 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe' [patent_app_type] => 1 [patent_app_number] => 8/371576 [patent_app_country] => US [patent_app_date] => 1995-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2875 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663061.pdf [firstpage_image] =>[orig_patent_app_number] => 371576 [rel_patent_id] =>[rel_patent_doc_number] =>)